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The quality difference of six varieties Ganoderma lucidum with different origins was inves-
tigated in this study by comparing the contents of ganoderic acid A and B, polysaccharide,
and triterpenoids. The contents of ganoderic acid A and B in G. lucidum were analyzed by
ultra performance liquid chromatography (UPLC). There was higher content of ganoderic
acid A in G. lucidum of Dabie Mountain and Longquan.The G. lucidum from Longquan has
the highest content of ganoderic acid B. The content of polysaccharide was determined
by Anthrone–sulfuric acid method. The highest of polysaccharide content is G. lucidum
from Liaocheng. The content of triterpenoid in G. lucidum was quantiﬁed by ultraviolet
spectrophotometer at 548.1 nm using Ursolic acid as standard.The G. lucidum from Dabie
Mountain has the highest content of triterpenoids. In summary, the content of ganoderic
acid A and B, polysaccharide, and triterpenoids in G. lucidum with different origins are
remarkably different, which may be caused by the conditions of cultivation and geographic
environment.
Keywords: Ganoderma lucidum, ganoderic acid A, ganoderic acid B, polysaccharide, triterpenoids, content
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INTRODUCTION
Ganoderma lucidum Karst a medicinal fungus, belonging to Basid-
iomycetes, Aphyllophorales, Ganodermataceae, is widely used in
Oriental medicine to maintain health.With both edible and medi-
cinal value, it hasmore than 2000 years of history inChina.And the
annual output of G. lucidum is over 10000 tons. G. lucidum has the
function of anti-aging, enhancing immunity, radioprotective, and
liver detoxiﬁcation as well as inhibiting malignant tumor growth
(Zhao et al., 1999; Lin, 2007; Lü et al., 2011). The chemical com-
position of G. lucidum is complex, which contains 11 categories
of active substances, such as polysaccharides, triterpenoids, fats
and oils, organic germanium, inorganic ions, and sterols. These
ingredients are closely related to their pharmacological activity
(el-Mekkawy et al., 2007). Polysaccharides and triterpenoids are
considered to be its main medicinal components (Wang and Sun,
1990; Zhao et al., 2002; Lin, 2007). The quality of G. lucidum is
evaluated though the content of polysaccharide in “Chinese Phar-
macopeia,” but Ganoderic acid in Japan (Zhang and Yang, 2006).
Ganoderic acid belongs to triterpenoids, which has a wide range
of pharmacological active components. It has become a hot study
subject in G. lucidum (Chen and Yu, 1990; Yang et al., 1995; Zhou
et al., 2004). Ganoderic acid A and B content account for more
than half of G. lucidum (Ding et al., 2009), so the determination
of ganoderic acid A and B content can be used as the scientiﬁc
basis for judging quality of G. lucidum.
Because wild fungus resources are limited and artiﬁcial culti-
vation of G. lucidum is affected by origin, cultivation, harvesting
conditions, and so on. These factors lead to different quality pro-
ductions of G. lucidum. We tested the G. lucidum samples from
some main producing areas in Shandong Liaocheng, Jiangsu Nan-
tong, Fujian Wuyi Mountain Zhejiang Longquan, Jilin Changbai
Mountain, and Anhui Dabie Mountain. The test is focused on the
contents of polysaccharide, triterpenoid, and ganoderic acidA and
B. The result is to provide the basis of procurement for using G.
lucidum as main raw materials.
MATERIALS AND METHODS
MATERIALS
Ganoderma lucidum karst is used for this experiment which
is respectively from the Shandong Liaocheng, Jiangsu Nantong,
FujianWuyiMountain,ZhejiangLongquan, JilinChangbaiMoun-
tain, and Anhui Dabie Mountain. In addition to G. lucidum from
Shandong Liaocheng cultured on cotton seed, others are wood
cultured.
INSTRUMENTS AND REAGENT
Waters Acquity ultra performance liquid chromatography
(UPLC), KQ-250E type ultrasonic cleaner (Kunshan Ultrasonic
Instrument Co., Ltd.), AB265-S/100000 electronic balance (Met-
tler Toledo). TU-1900 type ultraviolet–visible spectrophotometer
(Beijing Purkinje General Instrument Co., Ltd.). Standard gan-
oderic acid A, ganoderic acid B (purity >98%) provided by
Shanghai Tong Tian Biotechnology Co., Ltd. Urolic acid reference
substance provided by the national institute for the control of
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pharmaceutical and biological products. Acetonitrile (chromato-
graphic grade), double distilled water, phosphoric acid, chloro-
form, petroleum ether, ethyl acetate, methanol, and other reagents
are all analytically pure.
METHODS
Ganoderic acid A and ganoderic acid B content determination
Chromatographic conditions. The chromatographic columnwas
Waters X-BridgeC18 (4.6 mm× 150 mm, 3.5μm); the detection
wavelength was set at 252 nm; gradient elution, liquid phase gra-
dient ratio, and time relationships as shown in Table 1; the column
temperature was kept at 40˚C, and the ﬂow rate was 0.4 ml/min;
the injection volume was 10μl. In these chromatographic con-
ditions, ganoderic acid A and ganoderic acid B Mixed reference
substance, and G. lucidum extraction UPLC spectrum diagram as
shown in Figure 1.
PREPARATION OF STANDARD SOLUTION AND CALIBRATION CURVES
Precisely weighing amount of each reference substance and then
put it into a 10-ml volumetric ﬂask respectively, adding methanol
to dissolve and to the constant volume, reaching concentrations
Table 1 | Effect of different time of elution gradient ratio.
Time (min) Acetonitrile 0.03% phosphoric acid aqueous solution
0 30 70
5 30 70
50 35 65
60 60 40
of 1.802 mg/ml of ganoderic acid A and 1.020 mg/ml of ganoderic
acid B. Precisely weigh the liquid reserves each 8.0 ml in 25 ml
volumetric ﬂask, add methanol to scale, and shake to make mixed
standard stock solution of ganoderic acid A and ganoderic acid B
whose concentration are 0.577 and 0.326 mg/ml. Precisely weigh
standard stock solution 2.0–10 ml volumetric ﬂask, dilute to the
mark with methanol, and then shake to get mixed standard solu-
tion of ganoderic acidA andBwhosemass concentration are 0.100
and 0.065 mg/ml.
According to the method of Zhao et al. (2009), precisely mea-
sure mixed control solution 0.5, 1, 2, 4, 6, 8.0 to 10 ml volumetric
ﬂask, dilute to the mark with methanol, and shake to get a series of
standard solution. Respectively take a 10-μl sample of the mixed
standard solution to analyze under the chromatographic condi-
tions. Draw a standard curve and make regression calculation
with mass concentration of the reference as abscissa, peak area
as the ordinate, the results show that, the regression equation of
ganoderic acid A is Y = 1.9E+ 07X-122000 and ganoderic acid
B is R2 = 0.9996; Y = 2.0E+ 07X+ 139583, R2 = 0.9991. Gan-
oderic acid A and ganoderic acid B respectively in 28.85–400.8,
16.30–260.8μg/ml are in good linear relation.
Preparation of sample solution
According to the method of Liu (2008), the accurately weighed
powder sample (250 mg) was extracted with 100 ml chloroform by
the heating reﬂux for 1 h. The extract was ﬁltered with ﬁlter paper
which washed by methanol. After evaporating chloroform to dry-
ness by a rotary evaporator, residue was dissolved in methanol in
a 5-ml ﬂask, and then ﬁltered through a 0.45-μm membrane. Ten
microliters of sample solution were injected into the UPLC system
for analyzing.
FIGURE 1 | Mixed reference substance (A) and Ganoderma lucidum extraction (B) UPLC spectra.
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Precision test
According to the chromatographic conditions, taking ganoderic
acid A and ganoderic acid B mixed reference solution to successive
injection six time, and recording the peak area. The RSD of peak
area of ganoderic acid A and ganoderic acid B was 1.6 and 2.4%
respectively.
Repetitive test
Accurately weighed G. lucidum samples of six from Dabie Moun-
tain, according to methods of above, the RSD of contents of
ganoderic acidA and ganoderic acid B is 3.1 and 1.8% respectively.
The result shows that this method has a good repetitiveness.
Stability experiment
Take sample solution from Anhui Dabie Mountain for the test,
which is in 0, 2, 4, 6, 8, 10, 12, 24 h at room temperature and
record peak area. The results show that the sample solution has
good stability in 24 h and the RSD of peak area of ganoderic acid
A and ganoderic acid B were 0.9 and 1.4%.
Recovery rate test
Take nine portions of G. lucidum (0.25 g) from the Wuyishan
which the content of ganoderic acid A and ganoderic acid B are
known. Divide the portions into three groups and add the control
solution of low, middle, high concentrations of ganoderic acid A
and ganoderic acid B to each portion, then calculate the recovery
rate follow the method above. The result is as shown in Table 2.
Determination of polysaccharide
Sample preparation. Accurately weighing 2.0 g of power sample,
extracted by Soxhlet extractor with 90 ml water in the round-
bottom ﬂask, and heated under reﬂux for 6 h, then transfer the
Table 2 |The recovery rate test (n =3).
Composition Label Sample
quantity
(mg)
Adding
amount
(mg)
Recovery
rate (%)
RSD (%)
Acid A 1 0.5385 0.2481 95.4 1.41
2 0.5293 0.2417 97.6
3 0.5236 0.2352 94.4
4 0.5427 0.5228 97.7 1.02
5 0.5328 0.5173 95.9
6 0.5343 0.5284 98.6
7 0.5422 0.7362 98.1 1.28
8 0.5375 0.7340 100.1
9 0.5432 0.7274 99.4
Acid B 1 0.1745 0.0936 93.7 1.28
2 0.1715 0.0915 94.2
3 0.1697 0.0867 96.0
4 0.1759 0.1864 95.3 1.75
5 0.1726 0.1735 96.9
6 0.1731 0.1726 98.7
7 0.1757 0.2619 97.1 1.19
8 0.1742 0.2700 98.6
9 0.176 0.2623 99.4
extract to a 100 ml ﬂask, add water to the scale. Precisely mea-
sured 10 ml extract, added ethanol 150 ml, placed for 12 h at 4˚C.
The extract separated by centrifugal precipitation, the precipitate
is dissolve in water in a 50-ml ﬂask as the sample solution.
Preparation of standard curve. d-Glucose anhydrous (25 mg)
is accurately weighed and then dissolved in 25 ml of double dis-
tilled water, 1 ml solution is drawn to dilute 100 times with double
distilled water to produce corresponding stock standard solu-
tion (0.01 mg/ml). Accurately draw glucose control solution 0.2,
0.4, 0.6, 0.8, 1, 1.2 ml to the 10 ml test tube, add water to the
volume of 2.0 ml, precisely add anthrone–sulfuric acid [1.0 g of
anthrone was dissolved in sulfuric acid (80%) in a 100 ml ﬂask]
6 ml, heated for 15 min, then remove and put in ice-water to cool
for 15 min, with the corresponding reagent as control. Deter-
mine the absorbance in the 625 nm wavelength and make it as
the ordinate, concentration as abscissa to establish a standard
curve.
Precisely measure the sample solution 2 ml, put it into 10 ml
test tube, Follow the method of establishing the standard curve,
as the “precisely add anthrone–sulfuric acid 6 ml” begin to deter-
mine absorbance. Then calculate the content of the polysaccharide
according to the standard curve.
Triterpenoid determination
Preparation of standard curve. Accurately weigh 1.15 mg of
the ursolic acid, dissolve in 10 ml ethyl acetate to produce cor-
responding stock standard solution. Take 0, 0.10, 0.20, 0.40, 0.60,
0.80, 1, and 1.20 ml control solution to dryness in a water bath
at 100˚C. Then add 0.40 ml 5% vanillin–acetic acid solution and
1 ml perchloric acid, at 60˚C water bath heating for 15 min then
move it into ice-water bath, add 5 ml acetic acid, place it at room
temperature for 15 min.Determine its absorbance in the 548.1 nm.
Draw standard curve based on the determination result. Stan-
dard weight in 0–0.14 mg range showed a good linear relationship
with the absorbance value, the linear regression equation was
Y = 0.2158X− 0.001 8, correlation coefﬁcient r = 0.9991.
Extraction of triterpenoids. Triterpenoid extracts were prepared
by95%alcohol extraction as describedbefore (HouandLiu,2010).
Accurately weigh 200 g of dry G. lucidum powder for extraction.
Take G. lucidum extracts about 10 mg to dissolve in 10 ml ethyl
acetate, and determine its absorbance following themethod above.
RESULTS
CONTENT DETERMINATION OF DIFFERENT ORIGIN OF GANODERIC
ACID A AND GANODERIC ACID B
The content of ganoderic acid A and ganoderic acid B is as shown
in Table 3. The content of ganoderic acid A of Dabie Moun-
tain is the highest (7.254 mg/g); the followed behind is Longquan
(6.658 mg/g), Shandong (1.959 mg/g). Ganoderic acid B content
for Longquan (4.574 mg/g) is the highest.
CONTENT DETERMINATION OF POLYSACCHARIDE
The content of polysaccharide has signiﬁcant differences. The
highest content of G. lucidum polysaccharides is in Shandong, fol-
lowed by Wuyi Mountain (7.38%); the lowest (1.85%) is in Dabie
Mountain (see Table 4).
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Table 3 | Six kinds of ganoderic acid A and ganoderic acid B content.
Category Dabie mountain
(mg/g)
Longquan
(mg/g)
Nantong
(mg/g)
Changbai mountain
(mg/g)
Wuyi mountain
(mg/g)
Liaocheng
(mg/g)
Ganoderic acid A 7.254 6.658 3.563 2.618 2.154 1.959
Ganoderic acid B 0.337 4.574 0.574 1.450 0.698 2.078
Table 4 | Polysaccharide content of Ganoderma lucidum in different
regions.
Sample Mass fraction (%)
Dabie mountain 1.85
Longquan 5.88
Nantong 3.30
Changbai mountain 6.03
Wuyi mountain 7.38
Liaocheng 9.08
The SDs 2.64
CONTENT DETERMINATION OF TRITERPENOID
The content of triterpenoid from different origins has been shown
in Table 5. The highest content of triterpenoid of G. lucidum is
cultivated in Dabie mountain (5.38%), the lowest is in Longquan
(2.07%). The difference between them is signiﬁcant.
DISCUSSION
Triterpenoid and polysaccharide are as the basis of quality of Gan-
oderma product. Triterpenoid has signiﬁcant effect in immune
regulation and antitumor (Morigiwa et al., 1986; Ceng and Bao,
2004; Huang and Xiao, 2008); its content decides the antitu-
mor effect of G. lucidum products. Polysaccharide has the func-
tion of improving immunity, antitumor effects, removing free
radical, hypoglycemic, lipid-lowering (Xu and Xu, 2003), and
other functions. In recent years, the study has attracted many
researchers (Lin et al., 2002; Cao and Lin, 2004). Ganoderic
acid B and lucidenic acid A have the inhibitory activity against
HIV-1 protease (Min et al., 1998). For the reason of above,
we got the main medical ingredients of G. lucidum from six
origins.
Through this experimental data, both the triterpenoid and
ganoderic acid B are the highest in G. lucidum from Dabie moun-
tain. But the highest polysaccharide of artiﬁcial Cultivation G.
lucidum is from Liaocheng. There are several reasons impacting
the accumulation of polysaccharides and triterpenoids. First, the
same species of G. lucidum from different origins due to the cul-
ture medium, the growth environment, different stages of growth,
and covered soil or not, will have different polysaccharide con-
tent (Li et al., 1997; Ding et al., 1999; Wei et al., 2006; Chen et al.,
2009; Ye et al., 2010). Second, the content of polysaccharide and
Table 5 |Triterpenoid content of Ganoderma lucidum in different
regions.
Sample Mass fraction (%)
Dabie mountain 5.38
Longquan 2.07
Nantong 3.95
Changbai mountain 3.06
Wuyi mountain 4.33
Liaocheng 3.51
The SDs 1.13
triterpenoid is different in varieties of G. lucidum (Liu et al., 1999;
Xing and Jiang, 2001; Xing et al., 2004; Zheng et al., 2007). Third,
some research suggests that the different drying methods have
some effect in the content of polysaccharide of G. lucidum. The
own drying for G. lucidum is signiﬁcantly higher than the direct
drying in polysaccharide content,which is considered to be hydrol-
ysis, induced by hydrolytic enzymes (Xing and Jiang, 2001). The
content of polysaccharide is higher in asporogenous G. lucidum
than in sporiparous G. lucidum. The different parts of G. lucidum
have different content of polysaccharide (Shi et al., 2010). Maybe
due to the superior cultivation environment in Dabie Mountain,
the triterpenoid content is highest in G. lucidum. There maybe
some relations between the high polysaccharide content and the
culture medium in Liaocheng where the only G. lucidum were
cultured on cotton seed.
CONCLUSION
This study gives a comprehensive assessment of the G. Lucidum
in terms of its efﬁcacy and material, it provides shallow
datum for the G. Lucidum quality from different areas. The
result of the experiment indicated that there was no distinc-
tion correlation between polysaccharide and triterpenoid con-
tents. Because of the difference in active ingredient from dif-
ferent origins, we can choose the G. lucidum according to our
purposes.
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